Biondo Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.3M | Buy |
|
|||||
|
2023
Q1 | $323K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $10.5M | Buy |
|
|||||
|
2021
Q2 | $14.3M | Buy |
|
|||||
|
2021
Q1 | $10.1M | Sell |
|
|||||
|
2020
Q4 | $14.1M | Buy |
|
|||||
|
2020
Q3 | $9.71M | Buy |
|
|||||
|
2020
Q2 | $15.5M | Buy |
|
|||||
|
2020
Q1 | $12.6M | Sell |
|
|||||
|
2019
Q4 | $18.4M | Buy |
|
|||||
|
2019
Q3 | $5.91M | Buy |
|
|||||
|
2019
Q2 | $6.9M | Buy |
|